Seaport Therapeutics, Inc. (SPTX) stock
SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.32+0.01 (+0.05%)
Close on Nov 19, 2026Market cap $980.68MP/E –Yield –
Seaport Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Seaport Therapeutics's shares outstanding was 54M at Sep 30, 2026.
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 54M | +2171.3% |
| Q2 FY2026 | Jun 30, 2026 | 35M | +1416.4% |
| Q1 FY2026 | Mar 31, 2026 | 2M | – |
| Q3 FY2025 | Sep 30, 2025 | 2M | – |
| Q2 FY2025 | Jun 30, 2025 | 2M | – |
| Q1 FY2025 | Mar 31, 2025 | 2M | – |
See a number that looks wrong?